SpaceX
SPCX
$135.92
-3.81%
Space Exploration Technologies Corp. (SpaceX) designs, manufactures, and operates a family of reusable launch vehicles for government and commercial payload customers, and since 2019 has deployed the Starlink broadband constellation, which now anchors a Connectivity segment generating roughly $5.25 billion of quarterly revenue versus $1.77 billion from the legacy Space launch business. The company is the dominant global launch provider and the largest satellite broadband operator by subscriber count, giving it a vertically integrated platform spanning launch, spectrum, satellites, and now — following the early-2026 acquisition of xAI — large language models (Grok), the Colossus gigawatt-scale data center, and the X social network. The investor narrative has pivoted sharply from a pure space-and-broadband growth story to a contested AI-and-connectivity conglomerate: the Q3 2026 earnings beat, driven by explosive AI revenue growth, sent shares surging, while management's commentary about a potential Tesla merger has become an even bigger swing factor for the equity. At the same time, SpaceX's push into direct-to-cell mobile services is now being framed as a structural threat to incumbent wireless carriers, adding a regulatory and competitive overhang that cuts both ways for the bull case.…
SPCX
SpaceX
$135.92
Related headlines
Investment Opinion: Should I buy SPCX Today?
Rating: Hold, with a speculative-growth tilt. The thesis is that SpaceX has genuinely transformed into a high-margin AI-and-connectivity platform — Q3 2026 revenue of $14.575 billion, gross margin of 62.4%, and EBITDA margin of 57.2% are elite — but at $141.31 the stock already discounts years of flawless execution, and the 31-of-36 Buy consensus with a $257.11 average target (+82%) reflects stale modeling given the $70-$800 target spread. The risk/reward is asymmetric only for investors who can tolerate a 25-50% drawdown while waiting for the next several earnings prints to validate the AI and Starlink ramp.
Supporting evidence is mixed but leans constructive on fundamentals and cautious on price. Revenue roughly tripled in two quarters ($4.694 billion in Q1 to $7.814 billion in Q2 to $14.575 billion in Q3), gross margin expanded from 49.1% to 55.3% to 62.4%, and Q3 net income of $4.404 billion marked a 30.2% net margin versus a $541 million Q2 loss. Against that, the stock trades at 25.22x sales and 58.31x EV/Sales — far above Aerospace & Defense primes in the low-to-mid single digits — with a 55.10x forward PE requiring consensus forward EPS of $9.79 versus a trailing loss of -$0.0105, and TTM free cash flow of -$39.271 billion funded by an $85.88 billion Q2 equity raise. The +82% implied upside to the average target is real but should be read as a measure of how far the stock has fallen from where analysts modeled it, not as a near-term catalyst.
The biggest risks that could invalidate the thesis are (1) the Q3 revenue step-up proving largely inorganic and non-recurring, (2) AI monetization stalling while capex of $19.593 billion per quarter continues, and (3) multiple compression toward aerospace norms if growth decelerates. This Hold would upgrade to Buy if the stock pulls back toward the $105-$115 support zone (roughly -19% to -26%) while gross margin holds above 60% and Q4 revenue sustains above $14 billion, or if a credible Tesla merger structure is announced that is accretive rather than dilutive. It would downgrade to Sell if Q4 revenue falls below $10 billion, gross margin drops under 55%, or another large equity raise is announced at a discount to market. Valuation verdict: overvalued on absolute multiples relative to its industry, but fairly valued relative to its own growth trajectory if the AI and Starlink ramp persists — a stock priced for perfection that is not yet priced for failure.
Sign up to view all
SPCX 12-Month Price Forecast
The fundamental trajectory is genuinely impressive — revenue roughly tripled in two quarters, gross margin expanded from 49.1% to 62.4%, and Q3 swung to a $4.404 billion profit — but the stock at $141.31 already capitalizes years of that execution at 58.31x EV/Sales and 109.37x EV/EBITDA. The broken near-term momentum (-11.10% over one month, 30.5% of the 52-week range, relative strength of -9.11 versus SPY) suggests the debate will be settled by the next earnings print rather than by analyst enthusiasm, and the $257 average target should be treated as stale modeling given the 11x spread in targets. I would upgrade to bullish if Q4 revenue sustains above $14 billion with gross margin above 60% and free cash flow burn narrows, or if a credible Tesla merger structure emerges; I would downgrade to bearish if revenue falls below $10 billion, gross margin drops under 55%, or another discounted equity raise is announced. With a -46.35% historical max drawdown and a 1.79 short ratio offering no squeeze support, position sizing matters more than directional conviction here.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on SpaceX's 12-month outlook, with a consensus price target around $257.11 and implied upside of +89.2% versus the current price.
Average Target
$257.11
39 analysts
Implied Upside
+89.2%
vs. current price
Analyst Count
39
covering this stock
Price Range
$70 - $800
Analyst target range
Coverage is broad and overwhelmingly bullish: 36 analysts with 31 Buy ratings, 6 Hold, and 2 Sell, producing a consensus recommendation of "buy" and a mean recommendation score of 1.72 (where 1.0 is a strong buy). The average target price of $257.11 implies roughly +82% upside from the current $141.31, a strikingly aggressive consensus that reflects the post-Q3 earnings enthusiasm and the AI optionality embedded in the xAI acquisition. The recent institutional ratings flow confirms the bullish tilt — Pivotal Research, BofA Securities, UBS, Needham, TD Cowen, Wells Fargo, Cantor Fitzgerald, Macquarie, and Citigroup all reiterated Buy/Overweight/Outperform ratings around October 21-22 following the Q3 beat, with KeyBanc the lone Sector Weight. The consensus clearly leans bullish, but the magnitude of implied upside should be read as a signal of how far the stock has fallen from where analysts modeled it, not necessarily as a near-term catalyst. The target range is extraordinarily wide — from a low of $70.00 to a high of $800.00, a more than 11x spread — which signals very low conviction on terminal value and enormous dispersion in assumptions about the AI and Starlink ramp. The $800 high target implicitly assumes massive multiple expansion and sustained hypergrowth, likely modeling Starlink and xAI as dominant, high-margin platforms with a Tesla merger as an accelerant; the $70 low target prices in margin compression, competitive losses in direct-to-cell, heavy dilution, and a re-rating toward aerospace-and-defense norms. Consensus forward EPS estimates range from $0.37 to $48.77 and revenue estimates from $109.7 billion to $1.042 trillion, confirming that even the sell-side cannot agree on the basic scale of this business. Investors should treat the wide spread as a warning that price discovery is inefficient and that the stock will remain headline-driven and volatile.
Bulls vs Bears: SPCX Investment Factors
The bull case currently has stronger evidence: revenue tripled in two quarters to $14.575 billion, gross margin expanded to 62.4%, and 31 of 36 analysts rate the stock a Buy with an average target of $257.11 (+82%). But the bear case is not weak — a 58.31x EV/Sales multiple, -$39.271 billion TTM free cash flow, and a Q3 profit flattered by $1.223 billion of other income mean the market has already capitalized years of flawless execution. The single most important tension is whether the AI/xAI and Starlink revenue ramp is durable and organic enough to justify the multiple; if the sequential tripling proves largely inorganic or one-time, the stock re-rates violently toward the $70 low target, while sustained hypergrowth with margin expansion supports the path toward $257 and beyond. Near-term, the broken momentum (-11.10% over one month, price at 30.5% of range) suggests the debate will be settled by the next earnings print rather than by analyst enthusiasm.
Bullish
- Revenue tripled in two quarters: Q3 2026 revenue hit $14.575 billion versus $7.814 billion in Q2 and $4.694 billion in Q1, a sequential acceleration that dwarfs the reported 2.58% YoY figure (distorted by xAI consolidation). Connectivity alone now generates $5.248 billion quarterly versus $1.767 billion from Space launch, showing the business is scaling into a multi-platform infrastructure company.
- Elite margins with real operating leverage: Gross margin expanded from 49.1% in Q1 to 55.3% in Q2 to 62.4% in Q3, while EBITDA margin reached 57.2% ($8.333 billion) and operating margin turned positive at 19.1%. Q3 net income of $4.404 billion (30.2% net margin) versus a $541 million Q2 loss demonstrates the model can convert scale into profit.
- Analyst consensus overwhelmingly bullish: 31 of 36 analysts rate SPCX a Buy (mean score 1.72), with an average target of $257.11 implying +82% upside from $141.31. Nine institutions including BofA, UBS, Needham, Wells Fargo, and Citigroup reiterated Buy/Overweight around October 21-22 following the Q3 beat.
- Valuation multiples compressing on growth: PS ratio fell from 133.18x in Q1 2026 to 128.22x in Q2 and 123.61x in Q3, and PB dropped from 15.03x to 10.19x, as revenue and book value grew faster than price. The stock is cheaper on sales than at any point since its June 2026 listing even as the absolute multiple remains extreme.
Bearish
- Extreme valuation on every metric: EV/Sales of 58.31x, EV/EBITDA of 109.37x, and price-to-cash-flow of 69.41x sit far above typical Aerospace & Defense primes in the low-to-mid single digits on sales. The 55.10x forward PE requires consensus forward EPS of $9.79 versus a trailing loss of -$0.0105, leaving no room for execution error.
- Massive cash burn and dilution risk: Q3 operating cash flow of $9.631 billion was overwhelmed by $19.593 billion of capex, producing -$9.962 billion of quarterly free cash flow and -$39.271 billion TTM. The Q2 raise of $85.88 billion in common stock issuance shows the buildout is funded externally, keeping dilution and financing conditions live risks.
- Q3 profit quality is questionable: The $4.404 billion net income was flattered by a $1.223 billion positive other-income line and a -$390 million tax benefit, while R&D remained enormous at $4.596 billion. Trailing net margin is still -26.4% and ROE is -11.95%, so extrapolating the Q3 swing is dangerous.
- Momentum has broken down: Despite +448% over one year, SPCX trades at just 30.5% of its 52-week range ($104.83-$225.64) and is down 11.10% over the past month versus a -1.99% SPY. The 1-month relative strength of -9.11 and failure to hold the $171.92 October 6 high argue for caution until price reclaims the $150s.
SPCX Technical Analysis
SPCX is in a powerful but violently volatile uptrend: the stock is up 448.05% over the past year and 542.90% over six months, yet it trades at just 30.5% of its 52-week range (low $104.83, high $225.64) at a current price of $141.31. That combination — enormous trailing gains but price sitting in the lower third of the annual range — tells you the stock made its high early (near the June 2026 listing pop above $200) and has spent months digesting that move. The maximum drawdown of -46.35% confirms this is a high-beta momentum name where position sizing matters more than directional conviction. Recent momentum has turned negative and is diverging from the long-term trend: the stock is down 11.10% over the past month versus a 30.52% gain over three months, and its 1-month relative strength of -9.11 against SPY's -1.99% shows it is now lagging a flat-to-weak tape. That divergence looks like mean reversion after a parabolic run rather than a clean trend reversal, but the failure to hold the October spike near $171.92 (October 6) and the subsequent slide to $134.72 by October 30 argue for caution until price reclaims the $150s. Key levels are well defined: support sits at the $104.83 52-week low, with intermediate support around the $108-$115 zone that held in late July and early August, while resistance is the $171-$172 October swing high and then the $225.64 annual high. A breakout above $172 would signal the post-listing consolidation is over and reopen the path toward the highs, whereas a breakdown below $108 would confirm a lower-high/lower-low structure and likely target the 52-week low. With a short ratio of only 1.79 and volume of 73.3 million shares, there is no crowded short base to fuel a squeeze — moves will be driven by news flow, and the 3.62% single-day pop on November 3 shows how sharply the stock can gap.
Beta
—
—
Max Drawdown
-46.4%
Largest decline past year
52-Week Range
$105-$226
Price range past year
Annual Return
+428.5%
Cumulative gain past year
| Period | SPCX Return | S&P 500 |
|---|---|---|
| 1m | -20.6% | -1.0% |
| 3m | +18.3% | -0.2% |
| 6m | +518.4% | +4.0% |
| 1y | +428.5% | +13.6% |
| ytd | +523.2% | +12.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SPCX Fundamental Analysis
Revenue is inflecting violently upward: Q3 2026 revenue hit $14.575 billion, up from $7.814 billion in Q2 and $4.694 billion in Q1, a sequential acceleration that dwarfs the reported 2.58% year-over-year growth figure (which is distorted by the xAI consolidation and share-count changes). The segment mix shows Connectivity at $5.248 billion and Space at $1.767 billion, meaning the AI/xAI assets acquired in early 2026 are now contributing the majority of the top line and are the primary driver of the growth story. This trajectory — roughly tripling revenue in two quarters — supports the bull case that SpaceX is becoming an AI infrastructure and connectivity platform rather than a launch company, though investors should recognize that a large share of the step-up is inorganic. Profitability has swung decisively positive: Q3 net income was $4.404 billion (a 30.2% net margin) versus a $541 million loss in Q2 and a $4.276 billion loss in Q1, with gross margin expanding from 49.1% in Q1 to 55.3% in Q2 and 62.4% in Q3. Operating income of $2.791 billion (19.1% operating margin) and EBITDA of $8.333 billion (57.2% EBITDA margin) confirm real operating leverage, though R&D of $4.596 billion remains enormous and the trailing net margin is still -26.4% because of the Q1 writedown. The swing from -91.1% net margin in Q1 to +30.2% in Q3 is dramatic enough that investors should scrutinize the one-time items — a $1.223 billion positive other-income line and a -$390 million tax benefit flattered Q3 — before extrapolating. The balance sheet is liquid but cash-hungry: cash at period end was $53.386 billion against a debt-to-equity ratio of 0.554 and a current ratio of 1.446, and the company generated $9.631 billion of operating cash flow in Q3 but burned $19.593 billion on capex, producing -$9.962 billion of free cash flow (TTM FCF of -$39.271 billion). ROE is -11.95% on a trailing basis, and the Q2 capital raise of $85.88 billion in common stock issuance shows the company is funding its AI and constellation buildout externally rather than internally. That is acceptable for a hypergrowth infrastructure story, but it means dilution risk and financing conditions are live variables, and the negative FCF yield makes any cash-flow-based valuation framework inapplicable today.
Quarterly Revenue
$14.6B
2026-09
Revenue YoY Growth
+258.0%
YoY Comparison
Gross Margin
62.4%
Latest Quarter
Free Cash Flow
$-39.3B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SPCX Overvalued?
Because trailing net income is negative (EPS of -$0.0105, trailing PE of -95.24x), the PE ratio is not a usable primary metric; I am leading with the price-to-sales ratio of 25.22x and the EV/Sales multiple of 58.31x, cross-checked against the forward PE of 55.10x. The gap between the negative trailing PE and a 55.1x forward PE implies the market expects a dramatic earnings inflection — consensus forward EPS of $9.79 versus a trailing loss — which is a very high bar and leaves little room for execution error. EV/EBITDA of 109.37x and a price-to-cash-flow ratio of 69.41x confirm the stock is priced for hypergrowth rather than current cash generation. Peer comparison is difficult because no industry-average multiples were supplied in the valuation data, but contextually a 25.2x sales multiple and 58.3x EV/Sales sit far above typical Aerospace & Defense norms (large primes generally trade in the low-to-mid single digits on sales) and are more characteristic of high-growth AI infrastructure names. The premium is defensible only if the AI and Starlink revenue ramp persists — the 62.4% gross margin and 57.2% EBITDA margin in Q3 are genuinely elite and support a premium, but the 58.3x EV/Sales multiple already capitalizes years of that margin expansion. On historical context, the stock's own multiples have compressed as revenue surged: PS ratio fell from 133.18x in Q1 2026 to 128.22x in Q2 and 123.61x in Q3 on the historical ratios data, while PB moved from 15.03x to 10.19x over the same span. That compression is mechanical — the denominator (revenue and book value) grew faster than the price — and it means the stock is cheaper on sales than at any point since listing, even as the absolute multiple remains extreme. The PEG ratio of 0.0035 is essentially meaningless given the near-zero trailing earnings base and should be disregarded.
PE
-95.2x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
39.4x
Industry PE ~39.4x*
EV/EBITDA
109.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are substantial and quantifiable. Free cash flow is deeply negative at -$39.271 billion TTM, with Q3 alone burning -$9.962 billion as $19.593 billion of capex dwarfed $9.631 billion of operating cash flow, meaning the AI and constellation buildout depends on external financing — evidenced by the $85.88 billion common stock raise in Q2. Q3 net income of $4.404 billion was flattered by a $1.223 billion positive other-income line and a -$390 million tax benefit, while R&D of $4.596 billion remains enormous and trailing ROE is -11.95%. Revenue concentration is also a live concern: Connectivity at $5.248 billion and the newly consolidated AI assets now dominate the top line, so any slowdown in Starlink subscriber growth or AI monetization would hit the majority of revenue at once.
Market and competitive risks center on valuation compression and the direct-to-cell overhang. At 58.31x EV/Sales and 109.37x EV/EBITDA, SPCX trades at a massive premium to Aerospace & Defense primes in the low-to-mid single digits on sales, leaving it exposed to any multiple normalization if growth decelerates. The stock's beta-like volatility is extreme — a -46.35% max drawdown and a 448% one-year gain — and its 1-month relative strength of -9.11 against a -1.99% SPY shows it now lags a weak tape. Recent news highlights emerging threats: SpaceX's mobile push triggered a T-Mobile sell-off on October 23, and the potential Tesla merger introduces regulatory and shareholder hurdles that could distract management or dilute the AI narrative.
The worst-case scenario is a chain in which the next earnings print reveals the Q3 revenue step-up was largely inorganic, AI monetization stalls, and financing conditions tighten, forcing another large equity raise. That combination would compress the EV/Sales multiple toward aerospace norms and drive the stock toward its 52-week low of $104.83, a roughly -26% decline from $141.31, with the analyst low target of $70 implying a -50% downside if margin compression and direct-to-cell losses materialize. Given the -46.35% historical max drawdown, a move to the $70-$105 zone is entirely within the stock's demonstrated range, and investors should size positions assuming a 25-50% drawdown is plausible in an adverse scenario.
FAQ
Ranked by severity: first, financial and dilution risk — TTM free cash flow is -$39.271 billion, Q3 alone burned -$9.962 billion as $19.593 billion of capex dwarfed $9.631 billion of operating cash flow, and the $85.88 billion Q2 equity raise shows the buildout depends on external financing, so another discounted raise is a live threat. Second, valuation compression risk — at 58.31x EV/Sales and 109.37x EV/EBITDA, any growth deceleration would force a re-rating toward aerospace norms, and the -46.35% historical max drawdown shows how fast that can happen. Third, earnings-quality and concentration risk — Q3 net income of $4.404 billion was flattered by a $1.223 billion positive other-income line and a -$390 million tax benefit, while Connectivity ($5.248 billion) and the newly consolidated AI assets now dominate the top line, so a slowdown in either hits most of revenue at once. Fourth, competitive and regulatory risk — the direct-to-cell push already pressured T-Mobile on October 23, and a potential Tesla merger introduces shareholder and regulatory hurdles that could distract management or dilute the AI narrative.
The 12-month outlook splits into three scenarios. The base case (55% probability, $140-$200) assumes sequential revenue growth decelerates to a more normal 10-25% per quarter, gross margin holds in the 55-62% band, and the stock consolidates between the $105-$115 support zone and the $171-$172 October high, ending modestly above current levels. The bull case (20% probability, $257-$400) requires Q4 revenue above $14 billion with gross margin above 60%, plus a credible Tesla merger or direct-to-cell win, re-rating the stock toward the $257.11 analyst average. The bear case (25% probability, $70-$105) assumes the Q3 step-up was inorganic, AI monetization stalls, and another discounted equity raise forces the multiple toward aerospace norms, targeting the $104.83 52-week low and potentially the $70 analyst low. The base case is most likely, and its key assumption is that the AI and Starlink ramp is durable enough for earnings to catch up to the multiple.
On absolute terms it is clearly overvalued relative to its industry: a 25.22x price-to-sales and 58.31x EV/Sales multiple sit far above Aerospace & Defense primes, which typically trade in the low-to-mid single digits on sales, and the 109.37x EV/EBITDA and 69.41x price-to-cash-flow confirm the stock is priced for hypergrowth rather than current cash generation. The trailing PE of -95.24x is unusable given negative earnings, so the 55.10x forward PE — requiring consensus forward EPS of $9.79 versus a trailing loss of -$0.0105 — is the key test, and it leaves no room for execution error. Relative to its own short history the picture is more nuanced: the PS ratio has compressed from 133.18x in Q1 2026 to 123.61x in Q3 and PB fell from 15.03x to 10.19x as revenue and book value grew faster than price, meaning the stock is cheaper on sales than at any point since its June 2026 listing. The market is therefore paying a premium that implies sustained hypergrowth and margin expansion; if that persists the multiple is defensible, but if growth decelerates the re-rating would be violent.
It depends entirely on your risk tolerance and time horizon. The risk/reward is genuinely asymmetric in both directions: 31 of 36 analysts rate it Buy with a $257.11 average target (+82% from $141.31), and the fundamental momentum is real — revenue tripled in two quarters to $14.575 billion with gross margin at 62.4%. But the downside is equally concrete: the stock trades at 58.31x EV/Sales and 55.10x forward PE, burns -$39.271 billion of TTM free cash flow, and sits at just 30.5% of its 52-week range after an -11.10% one-month slide. The biggest single risk is that the Q3 revenue step-up proves largely inorganic and the multiple compresses toward aerospace norms, a path toward the $104.83 52-week low (-26%) or the $70 analyst low (-50%). For a risk-tolerant investor building a small, deliberately sized position with a multi-year horizon, the setup is reasonable; for anyone needing near-term certainty or income (dividend yield is 0%), it is not a good buy at this price.
SPCX is structurally a long-term holding but practically a volatile trading vehicle, so the two are not mutually exclusive. The growth stage is early-commercialization hypergrowth — revenue tripled in two quarters to $14.575 billion, but trailing net margin is -26.4%, ROE is -11.95%, and the company pays no dividend (0% yield), so there is no income component and earnings visibility is low given the $0.37-$48.77 forward EPS estimate range. Volatility is extreme: the stock is up 448.05% over one year yet trades at 30.5% of its 52-week range, with a -46.35% max drawdown and a 1-month relative strength of -9.11 versus SPY, and a short ratio of only 1.79 means no squeeze support. A concrete minimum holding period of 18-24 months is appropriate to let several earnings prints validate the AI and Starlink ramp; short-term traders should treat the $104.83-$225.64 range and the $108-$115 support / $171-$172 resistance levels as the operative framework, with position sizing — not directional conviction — as the primary risk control.